BioSpace News Archive

Drug Development

Alnylam Presents Results From Natural History Study Of Patients With Familial Amyloidotic Cardiomyopathy (FAC) And Presents Complete Results From Phase II Clinical Trial For Revusiran, An Investigational RNAi Therapeutic For The Treatment Of FAC

March 16, 2015
·
13 min read
Business

Helix Biopharma Announces The Receipt Of Subscription Agreements For A Net CAD5.2 Million Private Placement

March 16, 2015
·
3 min read
Drug Development

Cleveland Biolabs Inc. Announces Completion Of Dosing In Phase I Study Of CBLB612 In Russian Federation

March 16, 2015
·
3 min read
Business

Orgenesis Appoints Itamar Raz As Newest Member Of Board Of Advisors

March 16, 2015
·
4 min read
Genetown

Cellceutix Advancing Treatment for Hidradenitis Suppurativa, Pre-IND Meeting Request To FDA

March 16, 2015
·
7 min read
Business

Digisonics Promotes Tony Fossile To Director Of Sales

March 16, 2015
·
1 min read
Business

Cannabis Science Inc. Subsidiary Michigan Green Technologies (MGT) Announces Key Progress With its Michigan State Initiatives & A New Advisory Board with Significant Board Member

March 16, 2015
·
4 min read
Business

Mission Therapeutics Ltd Appoints Paul Wallace As Chief Business Officer

March 16, 2015
·
3 min read
Drug Development

Akebia Therapeutics, Inc. Announces Presentation Of Results From Its Phase IIb Study Of AKB-6548 In Non-Dialysis Patients With Anemia Related To Chronic Kidney Disease At International Society of Nephrology’s World Congress Of Nephrology

March 16, 2015
·
10 min read
AxoGen, Inc. To Present At Canaccord Genuity’s Musculoskeletal Conference

March 16, 2015
·
1 min read